TOGA

The Thoracic Oncology Group of Australasia (TOGA) is a premier clinical trials research organization dedicated to improving outcomes for patients with lung cancer and mesothelioma. Formed by the merger of the Australasian Lung Cancer Trials Group (ALCTG) and the Australian Lung Cancer Foundation, TOGA coordinates multi-center clinical trials across Australia and New Zealand. The organization collaborates with international research groups, pharmaceutical companies, and academic institutions to evaluate novel therapeutic strategies, including immunotherapies and targeted agents. TOGA provides a robust infrastructure for investigator-initiated research and serves as a central hub for thoracic oncology expertise in the region.